|
| Status |
Public on Feb 05, 2018 |
| Title |
Cross-Species Approach Identifies MELK as a Potential Therapeutic Target in Prostate Cancer |
| Organisms |
Homo sapiens; Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
29437778 |
| |
| Submission date |
Jul 17, 2017 |
| Last update date |
Sep 23, 2019 |
| Contact name |
Chandra Chilamakuri |
| E-mail(s) |
datasubmissions@cruk.cam.ac.uk
|
| Organization name |
Cancer Research UK Cambridge Institute
|
| Street address |
Robinson Way
|
| City |
Cambridge |
| ZIP/Postal code |
CB2 0RE |
| Country |
United Kingdom |
| |
|
| Platforms (2) |
| GPL16791 |
Illumina HiSeq 2500 (Homo sapiens) |
| GPL17021 |
Illumina HiSeq 2500 (Mus musculus) |
|
| Samples (120)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE94570 |
Identification of MELK-regulated genes in prostate cancer cells using next-generation sequencing |
| GSE94574 |
A Cross-Species Approach Identifies MELK as a Potential Therapeutic Target in Prostate Cancer |
|
| Relations |
| BioProject |
PRJNA394748 |
Less...
More...